---
figid: PMC7573235__fcell-08-573599-g0003
figlink: pmc/articles/PMC7573235/figure/F3/
number: F3
caption: Schematic representation of the signaling pathways activated by AKT. Lines
  represent either direct or indirect activation (arrow head) or inactivation (blunt
  end) by AKT. Activation of cell surface growth factor receptors by ligands such
  as epidermal growth factor and platelet-derived growth factor leads to the automatic
  phosphorylation of specific tyrosine residues in some of the receptor cells through
  their intrinsic receptor tyrosine kinase (RTK) activity. In this pathway, PI3K phosphorylates
  phosphatidylinositol (3,4) diphosphate (PIP2) to phosphatidylinositol (3,4,5) triphosphate
  (PIP3). This is a key signaling intermediate for PI3K signaling.PIP 3 then induces
  AKT to form a plasma membrane target through its binding to the N-terminal PH domain
  of AKT, which changes the kinase from an inactive to an active state. AKT is then
  phosphorylated on Thr-308 and Ser-473 by PDK1 as well as ILK, respectively. Activated
  AKT mediates its multiple cellular functions by phosphorylating specific substrates
  (). PTEN is a lipid phosphatase that limits AKT activation by dephosphorylating
  PIP3 into PIP2.AKT induces a phosphorylation-dependent nucleus-cytoplasmic shuttle
  of p27, impairing its antiproliferative activity. Compared to AKT 1 (WT), the E17K
  mutant significantly increased v-Abl translational efficiency and promoted tumorigenesis;
  these events will be described in detail below.
pmcid: PMC7573235
papertitle: Effect of AKT1 (p. E17K) Hotspot Mutation on Malignant Tumorigenesis and
  Prognosis.
reftext: Ying Chen, et al. Front Cell Dev Biol. 2020;8:573599.
pmc_ranked_result_index: '96591'
pathway_score: 0.9767575
filename: fcell-08-573599-g0003.jpg
figtitle: Signaling pathways activated by AKT
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7573235__fcell-08-573599-g0003.html
  '@type': Dataset
  description: Schematic representation of the signaling pathways activated by AKT.
    Lines represent either direct or indirect activation (arrow head) or inactivation
    (blunt end) by AKT. Activation of cell surface growth factor receptors by ligands
    such as epidermal growth factor and platelet-derived growth factor leads to the
    automatic phosphorylation of specific tyrosine residues in some of the receptor
    cells through their intrinsic receptor tyrosine kinase (RTK) activity. In this
    pathway, PI3K phosphorylates phosphatidylinositol (3,4) diphosphate (PIP2) to
    phosphatidylinositol (3,4,5) triphosphate (PIP3). This is a key signaling intermediate
    for PI3K signaling.PIP 3 then induces AKT to form a plasma membrane target through
    its binding to the N-terminal PH domain of AKT, which changes the kinase from
    an inactive to an active state. AKT is then phosphorylated on Thr-308 and Ser-473
    by PDK1 as well as ILK, respectively. Activated AKT mediates its multiple cellular
    functions by phosphorylating specific substrates (). PTEN is a lipid phosphatase
    that limits AKT activation by dephosphorylating PIP3 into PIP2.AKT induces a phosphorylation-dependent
    nucleus-cytoplasmic shuttle of p27, impairing its antiproliferative activity.
    Compared to AKT 1 (WT), the E17K mutant significantly increased v-Abl translational
    efficiency and promoted tumorigenesis; these events will be described in detail
    below.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGF1
  - PTEN
  - ILK
  - PLP2
  - PIM1
  - PIM2
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - IGF1R
  - MTTP
  - SART3
  - IRS1
  - AKT2
  - AKT3
  - AKT1
  - TRAF6
  - MDM2
  - DDX21
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - RPS6KB1
  - RPS6KB2
genes:
- word: IGF-1
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: IGF-1
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: ILK
  symbol: ILK
  source: hgnc_symbol
  hgnc_symbol: ILK
  entrez: '3611'
- word: PIP2
  symbol: PLP2
  source: hgnc_symbol
  hgnc_symbol: PLP2
  entrez: '5355'
- word: Pim-1
  symbol: PIM1
  source: hgnc_symbol
  hgnc_symbol: PIM1
  entrez: '5292'
- word: Pim-2
  symbol: PIM2
  source: hgnc_symbol
  hgnc_symbol: PIM2
  entrez: '11040'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: IGF-IR
  symbol: IGFIR
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: IGF-IR
  symbol: IGFIR
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: Abl
  symbol: ABL
  source: hgnc_alias_symbol
  hgnc_symbol: MTTP
  entrez: '4547'
- word: p110
  symbol: p110
  source: hgnc_alias_symbol
  hgnc_symbol: SART3
  entrez: '9733'
- word: IRS-1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: ΑΚΤ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: ΑΚΤ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: ΑΚΤ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: HDM2
  symbol: HDM2
  source: hgnc_alias_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: DDX21
  symbol: DDX21
  source: hgnc_symbol
  hgnc_symbol: DDX21
  entrez: '9188'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC1
  entrez: '4772'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC2
  entrez: '4773'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC3
  entrez: '4775'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC4
  entrez: '4776'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFAT5
  entrez: '10725'
- word: p70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: p70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB2
  entrez: '6199'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
chemicals: []
diseases: []
figid_alias: PMC7573235__F3
redirect_from: /figures/PMC7573235__F3
figtype: Figure
---
